You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Details for Patent: 6,080,721


✉ Email this page to a colleague

« Back to Dashboard


Title: Pulmonary delivery of active fragments of parathyroid hormone
Abstract:Systemic delivery of parathyroid hormone to a mammalian host is accomplished by inhalation through the mouth of a dispersion of an N-terminal fragment of PTH. It has been found that such respiratory delivery of the PTH fragment provides a pulsatile concentration profile of the PTH in the host's serum. PTH fragment compositions include dry powder formulations having the PTH present in a dry bulking powder, liquid solutions or suspensions suitable for nebulization, and aerosol propellants suitable for use in a metered dose inhaler.
Inventor(s): Patton; John S. (San Carlos, CA)
Assignee: Inhale Therapeutic Systems (San Carlos, CA)
Filing Date:Aug 03, 1998
Application Number:09/128,401
Claims:1. A method for delivery of a biologically active N-terminal fragment of parathyroid hormone (PTH) comprising administering to a mammal a pharmaceutical composition comprising said PTH fragment together with a pharmaceutically acceptable dry bulking powder, wherein said PTH fragment is present in said pharmaceutical composition as a dry powder having a mean particulate size in the range from 0.5 .mu.m to 5 .mu.m; and

wherein said composition is administered by inhalation.

2. A method as in claim 1, wherein the bulking powder is composed of a material selected from the group consisting of sucrose, lactose, trehalose, HSA, glycine, cellobiose, dextran, maltotriose, pectin, sodium citrate, sodium ascorbate, and mannitol.

3. A pharmaceutical composition comprising a biologically active N-terminal fragment of parathyroid hormone (PTH) present as a dry powder having a mean particulate size in the range from 0.5 .mu.m to 5 .mu.m; and a pharmaceutically acceptable dry bulking powder, wherein the PTH is present at from 1% to 25% by weight, wherein the dry powder is present as an aerosol in a gas.

4. A pharmaceutical composition as in claim 3, wherein the bulking powder is composed of a material selected from the group consisting of sucrose, lactose, trehalose, HSA, glycine, cellobiose, dextran, maltotriose, pectin, sodium citrate, sodium ascorbate, and mannitol.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.